Advertising Disclaimer
PEDIATRICS Vol. 99 No. 2 February 1997, pp. 268-278 (doi:10.1542/peds.99.2.268)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Related Collections
Right arrow Therapeutics & Toxicology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 99 No. 2 February 1997, pp. 268-278

AMERICAN ACADEMY OF PEDIATRICS:
"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)

Committee on Drugs

Because of an increasing number of reports of adverse reactions associated with pharmaceutical excipients, in 1985 the Committee on Drugs issued a position statement recommending that the Food and Drug Administration mandate labeling of over-the-counter and prescription formulations to include a qualitative list of inactive ingredients. However, labeling of inactive ingredients remains voluntary. Adverse reactions continue to be reported, although some are no longer considered clinically significant, and other new reactions have emerged. The original statement, therefore, has been updated and its information expanded.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Statement of retirement:

AAP Publications Retired, January 2004

Pediatrics 114: 506-506. [Full Text]



This article has been cited by other articles:


Home page
 PediatricsHome page
S. A. Thomson, C. Tuleu, I. C. K. Wong, S. Keady, K. G. Pitt, and A. G. Sutcliffe
Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children
Pediatrics, February 1, 2009; 123(2): e235 - e238.
[Abstract] [Full Text] [PDF]

Home page
 Poult. Sci.Home page
A. G. Lorenzoni and R. F. Wideman Jr.
Intratracheal Administration of Bacterial Lipopolysaccharide Elicits Pulmonary Hypertension in Broilers with Primed Airways
Poult. Sci., April 1, 2008; 87(4): 645 - 654.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Benninger, J. G. Mastronarde, and M. C. Exline
A 39-Year-Old Woman With Intractable Asthma
Chest, October 1, 2007; 132(4): 1397 - 1400.
[Full Text] [PDF]

Home page
 CephalalgiaHome page
U Reuter, M Sanchez del Rio, J. Carpay, C. Boes, S. Silberstein, and for the GSK Headache Masters Program
Placebo Adverse Events in Headache Trials: Headache as an Adverse Event of Placebo
Cephalalgia, September 1, 2003; 23(7): 496 - 503.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
S.-W. Huang and P. R. Borum
Study of Skin Rashes After Antibiotic Use in Young Children
Clinical Pediatrics, October 1, 1998; 37(10): 601 - 607.
[Abstract] [PDF]